Genitourinary Cancers | Tumor

BLA Has Been Submitted For Kidney Cancer Imaging PET Product Zircaix

January 8th 2025, 2:00pm

Article

A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.

CAR-T Cell Therapy Receives FDA Designation in Kidney Cancer Subset

October 30th 2024, 7:00pm

Article

Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.

Transurethral Ultrasound Ablation a Promising Prostate Cancer Treatment

October 14th 2024, 7:00pm

Article

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Removing More Lymph Nodes May Not Improve Survival in Muscle-Invasive Bladder Cancer

October 11th 2024, 9:00pm

Article

Removing more lymph nodes during surgery may also increase the risk for death after surgery in muscle-invasive bladder cancer.

You Can’t Spell Patient Without AI

October 8th 2024, 5:00pm

Article

Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a helpful tool.

Opdivo with Abraxane May Expand Therapeutic Opportunities For MIBC

October 4th 2024, 9:00pm

Article

Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.

Fotivda Shows Better Outcomes Than Combo in Metastatic Kidney Cancer

October 1st 2024, 1:00pm

Article

Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic kidney cancer.

Prostate Cancer Questions Answered on Surgery, Side Effects and More

September 27th 2024, 7:00pm

Article

An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.

Supplemental New Drug Application Submitted for Nubeqa in Prostate Cancer Subset

September 27th 2024, 1:00pm

Article

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials

September 26th 2024, 3:00pm

Article

An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.